MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss

M. Kmiecik, M. Mcintyre, B. Nguyen, A. Guan, M. Holmes, S. Aslibekyan (Sunnyvale, USA)

Meeting: 2025 International Congress

Keywords: Non-motor Scales, Parkinson’s

Category: Parkinson's Disease: Cognition / Psychiatric Manifestations / Lewy Body Dementia

Objective: Examine the interaction between APOE E4 and idiopathic Parkinson’s disease (PD) on age-related hearing loss using a validated web-based speech-in-noise assessment.

Background: Age is the primary risk factor for age-related hearing loss and neurodegenerative disease. Carriage of APOE E4 is associated with an increased risk of developing cognitive decline, including the processing of external stimuli (e.g., sound). However, evidence for the relationship between APOE E4 and age-related hearing loss is inconsistent, and has not been examined in a large-scale PD cohort.

Method: We sampled consented 23andMe, Inc. research participants between 50–85 years of age to complete an adaptive online speech-in-noise assessment. Participants listened to spoken digit-triplets and pressed the corresponding number keys in the order heard on their computer. Each participant’s speech recognition threshold (SRT) was calculated by estimating a logistic function and determining the SNR in decibels at 50% accuracy. Longitudinal surveys collected data on education, age, and PD diagnosis. We derived case-control status from the cumulative self-reported PD status, and SRT measurement may have preceded or followed PD diagnosis. Carriage of APOE E4 alleles was determined via genotyping. We used generalized additive models to regress SRT on PD diagnosis and APOE E4 status (carrier vs. non-carrier), adjusting for age, sex, education, 10 ancestry principal components, and genotyping platform. We applied a stratified penalized regression spline to model the nonlinear effect of age, allowing its shape to vary across combinations of PD and APOE E4 status. Main effects and interactions were compared using ANOVA.

Results: A total of n=4,282 idiopathic PD (23% APOE E4 carriers) and n=273,246 controls (25% APOE E4 carriers) were eligible for analysis. Greater hearing loss was observed in PD participants relative to controls (b=0.45dB, SE=0.05, p=2.64×10-21), and APOE E4 carriers relative to non-carriers (b=0.04dB, SE=0.01, p=2.91×10-4), when adjusted for covariates. Hearing loss increased non-linearly with age (effective degrees of freedom=7.03, p<2.22×10-308) and interacted with PD and APOE E4 status (ΔDeviance=72.85, p=0.008).

Conclusion: PD and APOE E4 carriage are associated with hearing loss and interact with age such that age-related hearing loss is more pronounced in PD participants carrying one or more APOE E4 alleles.

To cite this abstract in AMA style:

M. Kmiecik, M. Mcintyre, B. Nguyen, A. Guan, M. Holmes, S. Aslibekyan. Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/interactions-between-apoe-e4-and-idiopathic-parkinsons-disease-in-age-related-hearing-loss/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/interactions-between-apoe-e4-and-idiopathic-parkinsons-disease-in-age-related-hearing-loss/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley